• $14.4M
    Market Cap
  • -52.14%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
0
-100.00%
58,000
-87.84%
477,000
-64.72%
1.4M
+33.20%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
58,000
-87.84%
477,000
-64.72%
1.4M
+33.20%
Sales and Marketing Expense
3.3M
-9.69%
3.7M
-16.45%
4.4M
-0.54%
4.4M
-13.13%
Research and Development Expense
-5.0M
+13.11%
-4.4M
-43.22%
-7.7M
-12.54%
-8.8M
+3.23%
Depreciation and Amortization Expense
24,000
-64.18%
67,000
-20.24%
84,000
+2.44%
82,000
+36.67%
Total Operating Expenses
8.3M
+2.72%
8.1M
-33.51%
12.1M
-8.54%
13.3M
-2.87%
Operating Profit
-8.3M
+3.46%
-8.0M
-31.29%
-11.6M
-2.16%
-11.9M
-5.77%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
-100.00%
Total Nonoperating Income and Expense
50,000
-9.09%
55,000
-24.66%
73,000
+1,316.67%
-6,000
-185.71%
Income before Taxes
-8.3M
+3.46%
-8.0M
-31.29%
-11.6M
-2.16%
-11.9M
-5.77%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-8.2M
+3.55%
-7.9M
-31.33%
-11.6M
-2.82%
-11.9M
-5.67%
Net Income from Continuing Operations Applicable to Common
-8.2M
+3.55%
-7.9M
-31.33%
-11.6M
-2.82%
-11.9M
-5.67%
Basic EPS and Net Income
-1.23
-57.59%
-2.90
+427.27%
-0.55
-17.91%
-0.67
-10.67%
Diluted EPS and Net Income
-1.23
-57.59%
-2.90
+427.27%
-0.55
-17.91%
-0.67
-10.67%
Basic Weighted Average Shares
6.7M
+142.98%
2.7M
-87.05%
21.2M
+19.52%
17.7M
+4.75%
Diluted Weighted Average Shares
6.7M
+142.98%
2.7M
-87.05%
21.2M
+19.52%
17.7M
+4.75%
Balance Sheet
Cash and Cash Equivalents
2.5M
+5.27%
2.4M
+114.96%
1.1M
-85.02%
7.4M
-42.80%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.5M
+5.27%
2.4M
+114.96%
1.1M
-85.02%
7.4M
-42.80%
Total Current Assets
2.7M
+4.20%
2.6M
+79.47%
1.5M
-81.42%
7.9M
-41.67%
Accumulated Depreciation
785,000
+3.15%
761,000
+9.65%
694,000
+12.12%
619,000
+15.27%
Property and Plant and Equipment and Net
16,000
-51.52%
33,000
-64.89%
94,000
-44.71%
170,000
-6.59%
Total Long-Term Assets
171,000
0.00%
171,000
0.00%
171,000
0.00%
171,000
-0.58%
Total Assets
3.4M
-8.35%
3.7M
+24.67%
3.0M
-69.50%
9.8M
-37.70%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
18,000
N/A
Total Current Liabilities
2.4M
+4.78%
2.3M
-35.67%
3.6M
+0.64%
3.6M
-3.42%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
86,000
-84.81%
566,000
-42.36%
982,000
-25.38%
1.3M
-19.31%
Total Liabilities
2.5M
-12.78%
2.9M
-37.10%
4.6M
-6.35%
4.9M
-8.27%
Retained Earnings
-168.3M
+5.14%
-160.1M
+5.22%
-152.2M
+8.23%
-140.6M
+9.25%
Total Stockholders Equity
895,000
+6.93%
837,000
+152.21%
-1.6M
-132.77%
4.9M
-52.85%
Total Shares Outstanding
10.8M
+133.77%
4.6M
-80.56%
23.7M
+17.88%
20.1M
+19.00%
Cash Flow
Cash from Operating Activities
-7.4M
-7.35%
-8.0M
-19.53%
-10.0M
-5.56%
-10.6M
+1.88%
Capital Expenditures
7,000
+16.67%
6,000
-50.00%
12,000
-82.86%
70,000
-39.66%
Cash from Investing Activities
-7,000
+16.67%
-6,000
-50.00%
-12,000
-82.86%
-70,000
-39.66%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
7.6M
-18.62%
9.3M
+149.60%
3.7M
-27.25%
5.1M
+163.07%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-13,794.83%
+465.11%
-2,441.09%
+177.32%
-880.25%
-29.26%
Return on Assets
-230.57%
-2.63%
-236.81%
+30.77%
-181.08%
+93.98%
-93.35%
+44.73%
Return on Equity
-950.12%
-145.80%
2,074.67%
+394.86%
-703.62%
+351.08%
-155.98%
+82.58%
Revenue Growth
-100.00%
+13.84%
-87.84%
+35.73%
-64.72%
-294.92%
33.20%
-94.47%
Current Ratio
1.12
-0.56%
1.13
+179.01%
0.40
-81.54%
2.19
-39.60%
Cash Ratio
1.03
+0.47%
1.02
+234.15%
0.31
-85.12%
2.05
-40.77%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow